Stephanie Schneck

Oncology PharmD

[Nabil Adra @nabiladra]

Fortunate to work with an incredible team! IU group at GU ASCO @ClintCaryMD @JenniferKingMD @SalousTareq @schneckmate @IUCancerCenter @IUuro @IU_UroOnc @rebeccahassoun @AhmedBilalKhal2 @Noah_Onc #GU25

[Stephanie Schneck @schneckmate]

A very engaging presentation and discussion about high-dose chemotherapy in testicular cancer by @nabiladra at ASCO #GU25. Well done! @IUCancerCenter @IUuro

[Nabil Adra @nabiladra]

Management of relapsed primary retroperitoneal GCT. Data from @IUIntMed resident Kirsten Lewis @JenniferKingMD @SalousTareq @Noah_Onc @IUCancerCenter

[Nabil Adra @nabiladra]

Management of relapsed stage I seminoma with RP/pelvic only relapse. Careful selection for surgery is key. Data from @IUHemOnc star fellow @AhmedBilalKhal2 @JenniferKingMD @SalousTareq @Noah_Onc @IUCancerCenter

[Nabil Adra @nabiladra]

Neuropathy, rash, or hyperglycemia associated with improved PFS in UC pts treated with EV. @SalousTareq #GU25 @IUCancerCenter @rebeccahassoun @schneckmate @JenniferKingMD @Noah_Onc

[Nabil Adra @nabiladra]

Extended interval dosing of denosumab in metastatic prostate ca not associated with increased skeletal events. Data from GU pharmD @schneckmate from @IUCancerCenter @JenniferKingMD @SalousTareq @Noah_Onc #GU25

[Nabil Adra @nabiladra]

Xerostomia and ocular dryness predicted PSA response in pts with metastatic prostate ca treated with PSMA Lu177. Data from GU post doc @rebeccahassoun @IUCancerCenter @JenniferKingMD @SalousTareq @Noah_Onc @schneckmate #GU25